However, with future vaccination strategies that may include standardized amounts of NA in influenza vaccine formulations, it is necessary to implement a simple and safe standard second generation NI assay for the high-throughput screening of large numbers of sera to support vaccine development. The gene discussed is XK; the disease is influenza.